Product Information
KATERZIA 1 MG/ML SUSPENSION is a brand product labeled by Azurity Pharmaceuticals Inc., priced at $4.2111 per ML under NDC 52652500101. Its NADAC has been published 323 times since Apr 22, 2020.
Strength
1 mg/mL
Manufacturer
Azurity Pharmaceuticals Inc.NDC
52652500101
Classification
Brand
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMLODIPINE BENZOATEApproval Type
New Drug (NDA)
FDA Application
NDA211340On Market Since
8/15/2019
Pharmacological Classes
Price Statistics
The NADAC for KATERZIA 1 MG/ML SUSPENSION has been published 323 times since Apr 22, 2020, and over the history we have for it it has risen 33.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.2111 per ML |
|---|---|
| All-time high | $4.2151 (Jun 10, 2026) |
| All-time low | $3.1564 (Apr 22, 2020) |
| 52-week high | $4.2151 |
| 52-week low | $4.0607 |
| Median price | $3.5311 |
| Average price | $3.6099 |
| Largest weekly change | +9.0% (Jan 15, 2025) |
| Weeks tracked | 323 |
| Tracking since | Apr 22, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Amlodipine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of KATERZIA 1 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for KATERZIA 1 MG/ML SUSPENSION, manufactured by Azurity Pharmaceuticals Inc., is $4.2111 per ML (NDC 52652500101), effective Jun 24, 2026.
How has the price of KATERZIA 1 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for KATERZIA 1 MG/ML SUSPENSION has risen 33.4%. It has been tracked across 323 weekly CMS publications since Apr 22, 2020.
What are the highest and lowest recorded NADAC prices for KATERZIA 1 MG/ML SUSPENSION?
Since Apr 22, 2020, the NADAC for KATERZIA 1 MG/ML SUSPENSION has ranged from a low of $3.1564 (Apr 22, 2020) to a high of $4.2151 (Jun 10, 2026), with a median of $3.5311 per ML.
Are there cheaper alternatives to KATERZIA 1 MG/ML SUSPENSION?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of KATERZIA 1 MG/ML SUSPENSION, so no direct lower-cost alternative is listed.
Who manufactures KATERZIA 1 MG/ML SUSPENSION?
KATERZIA 1 MG/ML SUSPENSION (NDC 52652500101) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification